WO1998027969A3 - Antimicrobial phenazine compounds - Google Patents

Antimicrobial phenazine compounds Download PDF

Info

Publication number
WO1998027969A3
WO1998027969A3 PCT/CA1997/000978 CA9700978W WO9827969A3 WO 1998027969 A3 WO1998027969 A3 WO 1998027969A3 CA 9700978 W CA9700978 W CA 9700978W WO 9827969 A3 WO9827969 A3 WO 9827969A3
Authority
WO
WIPO (PCT)
Prior art keywords
phenazine
compounds
antimicrobial
phenazine compounds
growth
Prior art date
Application number
PCT/CA1997/000978
Other languages
French (fr)
Other versions
WO1998027969A2 (en
Inventor
Dick Zoutman
Kanji Nakatsu
Dragic Vukomanovic
Gerald Marks
James Brien
Original Assignee
Univ Kingston
Dick Zoutman
Kanji Nakatsu
Dragic Vukomanovic
Gerald Marks
James Brien
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kingston, Dick Zoutman, Kanji Nakatsu, Dragic Vukomanovic, Gerald Marks, James Brien filed Critical Univ Kingston
Priority to AU54719/98A priority Critical patent/AU5471998A/en
Publication of WO1998027969A2 publication Critical patent/WO1998027969A2/en
Publication of WO1998027969A3 publication Critical patent/WO1998027969A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Phenazine compounds having antimicrobial activity are described. The phenazine compounds can be phenazine N-oxides, including phenazine-5,10-dioxides, which may optionally be substituted at one or more positions, preferably the 7- and/or 8-positions of the phenazine nucleus. Also described are methods for treating microbial infections, and methods for inhibiting the growth of a microbial cell. The microbes treated or inhibited can be multidrug resistant. These compounds also inhibit the growth of tumor cells.
PCT/CA1997/000978 1996-12-24 1997-12-24 Antimicrobial phenazine compounds WO1998027969A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU54719/98A AU5471998A (en) 1996-12-24 1997-12-24 Antimicrobial phenazine compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3403596P 1996-12-24 1996-12-24
US60/034,035 1996-12-24

Publications (2)

Publication Number Publication Date
WO1998027969A2 WO1998027969A2 (en) 1998-07-02
WO1998027969A3 true WO1998027969A3 (en) 1998-10-01

Family

ID=21873904

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA1997/000978 WO1998027969A2 (en) 1996-12-24 1997-12-24 Antimicrobial phenazine compounds

Country Status (3)

Country Link
AU (1) AU5471998A (en)
CA (1) CA2247348A1 (en)
WO (1) WO1998027969A2 (en)

Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1103137A (en) * 1965-10-22 1968-02-14 Pfizer & Co C 1,2,3,4-tetrahydrophenazine-5,10-dioxides, and derivatives thereof useful in veterinary applications
GB1182617A (en) * 1967-06-09 1970-02-25 Shell Int Research Phenazine di-N-Oxides and Compositions containing them
US3530130A (en) * 1967-09-14 1970-09-22 Hoffmann La Roche 1-acylated-6-methoxyphenazine 5,10-dioxides
US3567728A (en) * 1968-07-05 1971-03-02 Pfizer Process for the preparation of phenazine di-n-oxides and related compounds
DE1695429A1 (en) * 1967-06-08 1971-04-15 Merck Patent Gmbh Process for the preparation of 1-methoxyphenazine-5,10-dioxide
US3586674A (en) * 1969-04-08 1971-06-22 Hoffmann La Roche Organometallic derivatives of 6-lower alkoxy 1-phenazinol 5,10-dioxide
US3609153A (en) * 1967-04-20 1971-09-28 Canadian Patents Dev 1 hydroxy 6 methoxy phenazines
GB1271194A (en) * 1970-04-03 1972-04-19 Pfizer PREPARATION OF QUINOXALINE-DI-N-OXIDES FROM o-QUINONEDIOXIME AND BUTENE-1,4 DIONES
US3678051A (en) * 1970-04-02 1972-07-18 Hoffmann La Roche Derivatives of 1,6-phenazinediol 5,10-dioxide
GB1285010A (en) * 1970-04-02 1972-08-09 Hoffmann La Roche Phenazine derivatives and a process for the manufacture thereof
US3700679A (en) * 1970-06-08 1972-10-24 Hoffmann La Roche Nuclear substituted derivatives of 1-hydroxy-6-methoxyphenazine 5,10-dioxide
FR2134012A1 (en) * 1971-04-23 1972-12-01 Hoffmann La Roche Myxin-metal complexes prodn - by reaction in aq suspension, having broad-sprectum antimicrobial activity
US3822265A (en) * 1966-11-25 1974-07-02 Hoffmann La Roche Phenazine derivatives
US3937707A (en) * 1972-05-01 1976-02-10 Hoffmann-La Roche Inc. 6-substituted 1-phenazinol 5,10-dioxide derivatives
US3985734A (en) * 1971-04-23 1976-10-12 Hoffmann-La Roche Inc. Method for the preparation of the copper complex of 6-methoxy-1-phenazinol 5,10-dioxide
US5637591A (en) * 1995-06-02 1997-06-10 Fuji Immunopharmaceuticals Corp. Antimicrobial and anticollagenase activity of phenazine-5, 10-dioxide and derivatives

Patent Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1103137A (en) * 1965-10-22 1968-02-14 Pfizer & Co C 1,2,3,4-tetrahydrophenazine-5,10-dioxides, and derivatives thereof useful in veterinary applications
US3822265A (en) * 1966-11-25 1974-07-02 Hoffmann La Roche Phenazine derivatives
US3609153A (en) * 1967-04-20 1971-09-28 Canadian Patents Dev 1 hydroxy 6 methoxy phenazines
DE1695429A1 (en) * 1967-06-08 1971-04-15 Merck Patent Gmbh Process for the preparation of 1-methoxyphenazine-5,10-dioxide
GB1182617A (en) * 1967-06-09 1970-02-25 Shell Int Research Phenazine di-N-Oxides and Compositions containing them
US3530130A (en) * 1967-09-14 1970-09-22 Hoffmann La Roche 1-acylated-6-methoxyphenazine 5,10-dioxides
US3567728A (en) * 1968-07-05 1971-03-02 Pfizer Process for the preparation of phenazine di-n-oxides and related compounds
US3586674A (en) * 1969-04-08 1971-06-22 Hoffmann La Roche Organometallic derivatives of 6-lower alkoxy 1-phenazinol 5,10-dioxide
US3678051A (en) * 1970-04-02 1972-07-18 Hoffmann La Roche Derivatives of 1,6-phenazinediol 5,10-dioxide
GB1285010A (en) * 1970-04-02 1972-08-09 Hoffmann La Roche Phenazine derivatives and a process for the manufacture thereof
GB1271194A (en) * 1970-04-03 1972-04-19 Pfizer PREPARATION OF QUINOXALINE-DI-N-OXIDES FROM o-QUINONEDIOXIME AND BUTENE-1,4 DIONES
US3700679A (en) * 1970-06-08 1972-10-24 Hoffmann La Roche Nuclear substituted derivatives of 1-hydroxy-6-methoxyphenazine 5,10-dioxide
FR2134012A1 (en) * 1971-04-23 1972-12-01 Hoffmann La Roche Myxin-metal complexes prodn - by reaction in aq suspension, having broad-sprectum antimicrobial activity
US3985734A (en) * 1971-04-23 1976-10-12 Hoffmann-La Roche Inc. Method for the preparation of the copper complex of 6-methoxy-1-phenazinol 5,10-dioxide
US3937707A (en) * 1972-05-01 1976-02-10 Hoffmann-La Roche Inc. 6-substituted 1-phenazinol 5,10-dioxide derivatives
US5637591A (en) * 1995-06-02 1997-06-10 Fuji Immunopharmaceuticals Corp. Antimicrobial and anticollagenase activity of phenazine-5, 10-dioxide and derivatives

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
GRUNBERG ET AL.: "Studies on the in vitro and in vivo chemotherapeutic properties of the antibiotic Myxin", CHEMOTHERAPIA, vol. 12, no. 5, 1967, pages 272 - 281, XP002062758 *
MAESTRONE ET AL.: "Chemotherapeutic activity of 6-methoxy-1-phenazinol 5,10-dioxide, cupric complex in experimentally induced local microbial infections in dogs", AM. J. VET. RES., vol. 35, no. 2, 1974, pages 281 - 284, XP002062759 *
MAESTRONE ET AL.: "Topical antimicrobial activity of 6-Methoxy-1-Phenazinol 5,10-dioxide, cupric complex", AM. J. VET. RES., vol. 33, no. 1, 1972, pages 185 - 193, XP002062754 *
MAESTRONE TE AL.: "Evaluation of Cuprimyxin-hydrocortisone acetate suspension in the treatment of otitis externa in dogs and cats", AM. J. VET. RES., vol. 40, no. 2, 1979, pages 285 - 287, XP002062755 *
MCDONALD ET AL.: "Antimicrobial susceptibility of Prototheca zopfii isolated from bovine intramammary infections", AM. J. VET. RES., vol. 45, no. 6, 1984, pages 1079- - 1080, XP002062756 *
SEKHON ET AL.: "Sensitivity of some human pathogenic yeasts and systemic fungi to myxin", ABSTR. ANNU. MEET. AM. SOC. MICROBIOL., vol. 75, 1975, pages 44, XP002062757 *

Also Published As

Publication number Publication date
WO1998027969A2 (en) 1998-07-02
CA2247348A1 (en) 1998-07-02
AU5471998A (en) 1998-07-17

Similar Documents

Publication Publication Date Title
IL143748A0 (en) Substituted aryl or heteroarylamides having retinoid-like biological activity
DK0637300T3 (en) Antiproliferative quinazolines
AU3885897A (en) Materials and method for treating or preventing pathogenic fungal infection
CA2190490A1 (en) Method and Compositions for Treating Recirculating Water Systems
WO2000034265A3 (en) Quinoline-indole antimicrobial agents
WO2001012606A3 (en) Tetrahydroquinoline derivatives having retinoid-like biological activity
EP1495754A3 (en) Method and composition for treating cancers
AU1810001A (en) Compounds, compositions, and methods for stimulating neuronal growth and elongation
ZA973487B (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment.
ZA200007642B (en) Treatment of airborne microorganisms.
WO1998036730A3 (en) Compositions for treating acne rosacea
AU1034901A (en) Method and installation for treating effluents, comprising an additional treatment of the sludge by ozonisation
MY118951A (en) Sunlight-ultraviolet-stable biocide compositions and uses thereof in water treatment
AU1792697A (en) Photosensitive composition
WO1998027969A3 (en) Antimicrobial phenazine compounds
ZA200203008B (en) Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis.
AU1860995A (en) Quinoline or quinazoline derivatives as anti-inflammatory agents, in particular for treating arthritis
WO2000020556A3 (en) Zinc finger-reactive antimicrobial compounds
CA2380455A1 (en) 9a-azalides with antibacterial activity
AU1074299A (en) Methods and kits for removing, treating or preventing lice
AU2429800A (en) Method for treating workpieces shaped like circular blanks, coins or the like
WO2001041709A3 (en) Methods for treating cell death diseases and inflammation
WO1998028299A3 (en) Imidazopyridazines
EP1110454A3 (en) 5-Carboxanilido-haloalkylthiazoles as antimicrobial and marine antifouling agents
AU6558100A (en) Enzymatic method for killing or inhibiting microbial cells at high ph

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU

ENP Entry into the national phase

Ref document number: 2247348

Country of ref document: CA

Kind code of ref document: A

Ref document number: 2247348

Country of ref document: CA

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase